Marcus Theatres Invites Moviegoers to “Make Summer Pop”

Marcus & Millichap Releases New Single-Tenant Retail Reports as Industry Gathers at ICSC Las Vegas

Marcus & Millichap Appoints National Director of Retail Division

Marcus & Millichap Q1 Earnings Call Highlights

Marcus & Millichap Capital Corporation Arranges $54 Million HUD Refinance for Houston-Area Multifamily Asset

Marcus Theatres Promotes Rob Novak to Executive Vice President of Operations and Food and Beverage

Marcus Corporation to Hold Virtual Annual Shareholders' Meeting May 21, 2026

Joel S. Marcus, Executive Chairman and Founder of Alexandria Real Estate Equities, Inc., Honored with the Prestigious Richard J. Bolte Sr. Award from the Science History Institute Museum & Library in Recognition of His Consequential Long-Term Impact on the Life Science Industry

The Marcus Corporation: Strong Theatres Offset Hotel Weakness, 25% Upside Remains

Marcus & Millichap's IPA Capital Markets Arranges $116.5 Million Construction Financing for Pacific Northwest Industrial Property

The Marcus Corporation (MCS) Q1 2026 Earnings Call Transcript

Marcus (MCS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Marcus (MCS) Reports Q1 Loss, Beats Revenue Estimates

Marcus Corporation Reports First Quarter Fiscal 2026 Results

AMC Entertainment (AMC) Expected to Beat Earnings Estimates: Should You Buy?

Letter to Shareholders from Marcus Lemonis, Executive Chairman and CEO: Q1 2026 Shareholder Letter

HYTN Announces Extension of Marketing Program

UNITE HERE Local 1 Releases Report Investigating Marcus Corporation Related Party Transactions

Marcus (MCS) Expected to Beat Earnings Estimates: Should You Buy?

Marcus & Millichap, Inc. to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Marcus & Millichap Closes Two Westside Los Angeles Multifamily Sales at Record Value

Marcus Corporation Announces First Quarter Fiscal 2026 Release Date and Conference Call

Jeffry F. Tomachek Promoted to President of Marcus Theatres

Kodiak Appoints Marcus Chalk to Board, Enhancing Strategic and Financial Expertise

Marcus Theatres Blasts to Highest Grossing Five-Day Easter Weekend

Marcus (NYSE:MCS) vs. RCI Hospitality (NASDAQ:RICK) Financial Survey

Letter to Shareholders from Marcus Lemonis, Executive Chairman and CEO: The Growth Phase

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2

Antimony Resources Corp. (ATMY) (ATMYF) (K8J0) Discovers Extension of the Massive Antimony-Bearing Stibnite Mineralization at the Marcus (West) Zone

UK's Trustpilot names The Economist Group's Marcus Roy as CFO

Marcus Corporation to Participate at the 38th Annual ROTH Conference

Marcus & Millichap's IPA Capital Markets Arranges $44 Million Financing for Luxury Los Angeles Multifamily Properties

Contrasting Avolta (OTCMKTS:DUFRY) and Marcus (NYSE:MCS)

HYTN Announces Extension of Marketing Program

Berkshire Hathaway Specialty Insurance Names Marcus Portbury Regional President, Asia Middle East

The Marcus Corporation: Still Cheap After The Q4 Run-Up

The Marcus Corporation (MCS) Q4 2025 Earnings Call Transcript

Marcus (MCS) Reports Q4 Earnings: What Key Metrics Have to Say

Marcus (MCS) Reports Q4 Loss, Tops Revenue Estimates

Marcus Corporation Reports Fourth Quarter and Full Year Fiscal 2025 Results

Letter to Shareholders From Marcus Lemonis, Executive Chairman and CEO: 2025 Year End Letter and 2026 Outlook

Marcus Corporation (The) (NYSE:MCS) Receives $23.50 Consensus Price Target from Brokerages

Earnings Preview: Marcus (MCS) Q4 Earnings Expected to Decline

Marcus & Millichap: High Forecasts, Fragile Backdrop

Antimony Resources Corp. (ATMY) (ATMYF) (K8J0) Continues to Expose New Massive Antimony-Bearing Stibnite Mineralization in the Marcus Zone

Marcus & Millichap, Inc. Reports Preliminary Results for Fourth Quarter and Full Year 2025

New Discovery of Massive Stibnite (Antimony) on Globex's Bald Hill Property

Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia

Marcus Corporation Announces Fourth Quarter and Full Year Fiscal 2025 Release Date and Conference Call

Marcus Corporation Declares Quarterly Dividend